United Therapeutics Corp

UTHR NMS
Pharmaceuticals
Silver Spring, MD
2016 Revenue (US$ Millions)$1,599
Revenue Growth (%)9.08%
2015 Revenue (US$ Millions)$1,466
Net Income (US$ Millions)$714
Common Shares Outstanding (Millions)42.97
Earnings Per Share (US$)$15.25
Price to Earnings Ratio9.61
Total Equity (US$ Millions)$1,862
Return on Equity (%)44.62%
Long Term Debt (US$ Millions)N/A
Debt to Equity Ratio (%)N/A
Market Capitalization (US$ Millions)$6,163
Total Assets (US$ Millions)$2,326
Current Assets (US$ Millions)$1,425
Inventories (US$ Millions)$100
Current Liabilities (US$ Millions)$333
Cost Of Goods Sold (US$ Millions)$73
Asset Turnover0.71
Inventory Turnover0.8